The Lancet: March 25, 2008
The Lancet in conversation with
English - March 25, 2008 07:00 - 12 minutes - 8.63 MBLife Sciences Science Education medicine research covid diseases science health care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Lancet: March 14, 2008
Next Episode: The Lancet: March 28, 2008
Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv